Generics Bulletin Editor’s Picks For Q4 2021

Highlights Across The Off-Patent Sector From October To December 2021

 
• By Dave Wallace

As 2021 drew to a close, there was no shortage of exciting developments for the off-patent industry. Alongside news of a strategic review affecting one of the biggest generics and biosimilars players, Generics Bulletin also held its annual Global Generics & Biosimilars Awards and brought readers fresh and exclusive insights from top industry executives.

Q4 Fourth Quarter Post-It Note Notice Board
The fourth quarter of 2021 brought a variety of developments • Source: Constantin Stanciu / Alamy Stock Photo

More from Generics

More from Products